Free Trial

Aktis Oncology (AKTS) Earnings Date, Estimates & Call Transcripts

Aktis Oncology logo
$20.03 +0.59 (+3.03%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$20.04 +0.00 (+0.02%)
As of 05/6/2026 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aktis Oncology Earnings Summary

Aktis Oncology posted Q4 2025 earnings on March 30, 2026, reporting an EPS of -$18.17. Quarterly revenue was reported to be $1.87 million. With a trailing EPS of $0.00, Aktis Oncology's earnings are expected to decrease next year, from ($1.44) to ($1.88) per share.

Upcoming
Earnings Date
May. 8Estimated
Actual Revenue
(Mar. 30)
$1.87M

Q4 2025 Earnings Resources

AKTS Upcoming Earnings

Aktis Oncology's Q1 2026 earnings is estimated for Friday, May 8, 2026, based on past reporting schedules

Get Aktis Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aktis Oncology and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

AKTS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AKTS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aktis Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.36-$0.14-$0.25
Q2 20262-$0.38-$0.13-$0.26
Q3 20261-$0.46-$0.46-$0.46
Q4 20261-$0.51-$0.51-$0.51
FY 2026 6 -$1.71 -$1.24 -$1.48
Q1 20271-$0.54-$0.54-$0.54
Q2 20271-$0.57-$0.57-$0.57
Q3 20271-$0.60-$0.60-$0.60
Q4 20271-$0.63-$0.63-$0.63

Aktis Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2026
(Estimated)
--------
3/30/2026Q4 2025--$18.17--$18.17-$1.87M
5/13/2024Q3 2024-$0.12-$0.14 -$0.02-$0.02$8.56M$7.51M

Data powered by Fiscal.ai.

Aktis Oncology Earnings - Frequently Asked Questions

Aktis Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 8th, 2026 based off last year's report dates. Learn more on AKTS's earnings history.

Aktis Oncology (NASDAQ:AKTS) has a recorded annual revenue of $6.50 million.

Aktis Oncology's earnings are expected to decrease from ($1.44) per share to ($1.88) per share in the next year.


This page (NASDAQ:AKTS) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners